Citigroup’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.5M Sell
340,977
-85,503
-20% -$3.38M 0.01% 877
2025
Q1
$12.9M Buy
426,480
+257,325
+152% +$7.76M 0.01% 875
2024
Q4
$5.91M Buy
169,155
+98,860
+141% +$3.46M ﹤0.01% 1284
2024
Q3
$2.82M Sell
70,295
-6,323
-8% -$253K ﹤0.01% 1781
2024
Q2
$3.65M Sell
76,618
-146,325
-66% -$6.97M ﹤0.01% 1350
2024
Q1
$9.66M Buy
222,943
+122,698
+122% +$5.32M 0.01% 908
2023
Q4
$5.07M Sell
100,245
-89,375
-47% -$4.52M ﹤0.01% 1126
2023
Q3
$8.6M Buy
189,620
+107,873
+132% +$4.89M 0.01% 842
2023
Q2
$3.35M Sell
81,747
-103,226
-56% -$4.24M ﹤0.01% 1335
2023
Q1
$6.61M Buy
184,973
+55,844
+43% +$2M ﹤0.01% 996
2022
Q4
$4.88M Sell
129,129
-47,863
-27% -$1.81M ﹤0.01% 1067
2022
Q3
$7.83M Buy
176,992
+27,861
+19% +$1.23M 0.01% 896
2022
Q2
$5.52M Buy
149,131
+67,795
+83% +$2.51M ﹤0.01% 1082
2022
Q1
$3.01M Sell
81,336
-104,711
-56% -$3.88M ﹤0.01% 1462
2021
Q4
$5.66M Buy
186,047
+64,983
+54% +$1.98M ﹤0.01% 1209
2021
Q3
$4.06M Sell
121,064
-121,059
-50% -$4.06M ﹤0.01% 1407
2021
Q2
$9.66M Buy
242,123
+7,103
+3% +$283K 0.01% 1072
2021
Q1
$10.6M Buy
235,020
+4,792
+2% +$215K 0.01% 990
2020
Q4
$13M Buy
230,228
+59,920
+35% +$3.39M 0.01% 839
2020
Q3
$8.08M Buy
170,308
+4,348
+3% +$206K 0.01% 931
2020
Q2
$9.79M Sell
165,960
-9,378
-5% -$553K 0.01% 780
2020
Q1
$8.29M Sell
175,338
-37,948
-18% -$1.79M 0.01% 728
2019
Q4
$12.9M Buy
213,286
+51,955
+32% +$3.14M 0.01% 721
2019
Q3
$9.67M Buy
161,331
+21,553
+15% +$1.29M 0.01% 810
2019
Q2
$8.98M Buy
139,778
+42,636
+44% +$2.74M 0.01% 862
2019
Q1
$7.89M Sell
97,142
-91,445
-48% -$7.42M 0.01% 814
2018
Q4
$10.2M Buy
188,587
+102,568
+119% +$5.55M 0.01% 696
2018
Q3
$4.44M Buy
86,019
+15,372
+22% +$793K ﹤0.01% 1061
2018
Q2
$2.95M Buy
70,647
+6,619
+10% +$276K ﹤0.01% 1274
2018
Q1
$2.82M Sell
64,028
-44,615
-41% -$1.97M ﹤0.01% 1269
2017
Q4
$5.46M Sell
108,643
-25,340
-19% -$1.27M ﹤0.01% 918
2017
Q3
$6.79M Buy
133,983
+522
+0.4% +$26.5K 0.01% 834
2017
Q2
$6.79M Buy
133,461
+28,017
+27% +$1.43M 0.01% 803
2017
Q1
$4.24M Sell
105,444
-23,467
-18% -$943K ﹤0.01% 995
2016
Q4
$6.17M Buy
128,911
+10,295
+9% +$493K 0.01% 896
2016
Q3
$4.35M Buy
118,616
+1,203
+1% +$44.1K ﹤0.01% 958
2016
Q2
$2.73M Buy
117,413
+46,919
+67% +$1.09M ﹤0.01% 1105
2016
Q1
$2.86M Buy
70,494
+3,774
+6% +$153K ﹤0.01% 1165
2015
Q4
$4.13M Sell
66,720
-23,167
-26% -$1.43M ﹤0.01% 970
2015
Q3
$3.63M Sell
89,887
-15,158
-14% -$613K ﹤0.01% 1009
2015
Q2
$6.05M Buy
105,045
+10,841
+12% +$624K 0.01% 779
2015
Q1
$6M Sell
94,204
-4,910
-5% -$313K 0.01% 800
2014
Q4
$6.12M Buy
99,114
+47,165
+91% +$2.91M 0.01% 753
2014
Q3
$2.02M Buy
51,949
+8,677
+20% +$337K ﹤0.01% 1276
2014
Q2
$1.49M Sell
43,272
-20,624
-32% -$710K ﹤0.01% 1396
2014
Q1
$2.76M Sell
63,896
-9,341
-13% -$404K ﹤0.01% 1096
2013
Q4
$2.92M Buy
73,237
+28,616
+64% +$1.14M ﹤0.01% 1145
2013
Q3
$1.68M Buy
44,621
+22,300
+100% +$837K ﹤0.01% 1307
2013
Q2
$600K Buy
+22,321
New +$600K ﹤0.01% 1923